COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 42,399 | 504,148 | SH | | SOLE | | 504,148 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 24,239 | 333,316 | SH | | SOLE | | 333,316 | 0 | 0 |
ABIOMED, Inc. | Common | 003654100 | 8,522 | 32,716 | SH | | SOLE | | 32,716 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 954 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
Acadia Healthcare Co., Inc. | Common | 00404A109 | 6,052 | 173,155 | SH | | SOLE | | 173,155 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 4,281 | 160,147 | SH | | SOLE | | 160,147 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 7,739 | 188,388 | SH | | SOLE | | 188,388 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 919 | 228,496 | SH | | SOLE | | 228,496 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 1,971 | 66,688 | SH | | SOLE | | 66,688 | 0 | 0 |
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 673 | 740,000 | SH | | SOLE | | 740,000 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 729 | 254,000 | SH | | SOLE | | 254,000 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 2,509 | 33,600 | SH | | SOLE | | 33,600 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 7,250 | 145,342 | SH | | SOLE | | 145,342 | 0 | 0 |
Albireo Pharma, Inc. | Common | 01345P106 | 3,390 | 105,154 | SH | | SOLE | | 105,154 | 0 | 0 |
Alcon Inc. | Ordinary Shares | H01301128 | 3,436 | 55,369 | SH | | SOLE | | 55,369 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 52,394 | 400,014 | SH | | SOLE | | 400,014 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 7,740 | 28,278 | SH | | SOLE | | 28,278 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 4,464 | 198,048 | SH | | SOLE | | 198,048 | 0 | 0 |
Allakos Inc. | Common | 01671P100 | 1,058 | 24,414 | SH | | SOLE | | 24,414 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 24,157 | 144,281 | SH | | SOLE | | 144,281 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 11,709 | 161,372 | SH | | SOLE | | 161,372 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 10,728 | 553,295 | SH | | SOLE | | 553,295 | 0 | 0 |
AmerisourceBergen Corp. | Common | 03073E105 | 11,960 | 140,273 | SH | | SOLE | | 140,273 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 134,461 | 729,658 | SH | | SOLE | | 729,658 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 3,926 | 314,597 | SH | | SOLE | | 314,597 | 0 | 0 |
AnaptysBio, Inc. | Common | 032724106 | 4,220 | 74,798 | SH | | SOLE | | 74,798 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 29,196 | 103,456 | SH | | SOLE | | 103,456 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 264 | 36,068 | SH | | SOLE | | 36,068 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 1,720 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 1,642 | 28,002 | SH | | SOLE | | 28,002 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 4,018 | 28,381 | SH | | SOLE | | 28,381 | 0 | 0 |
ArQule, Inc. | Common | 04269E107 | 1,675 | 152,110 | SH | | SOLE | | 152,110 | 0 | 0 |
Array BioPharma Inc. | Common | 04269X105 | 15,005 | 323,883 | SH | | SOLE | | 323,883 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 814 | 30,700 | SH | | SOLE | | 30,700 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 8,480 | 73,647 | SH | | SOLE | | 73,647 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 13,829 | 334,998 | SH | | SOLE | | 334,998 | 0 | 0 |
Atreca, Inc. | Class A Common | 04965G109 | 3,297 | 175,000 | SH | | SOLE | | 175,000 | 0 | 0 |
Audentes Therapeutics, Inc. | Common | 05070R104 | 1,990 | 52,574 | SH | | SOLE | | 52,574 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 2,354 | 814,588 | SH | | SOLE | | 814,588 | 0 | 0 |
Bausch Health Co. Inc. | Common | 071734107 | 4,257 | 168,812 | SH | | SOLE | | 168,812 | 0 | 0 |
Baxter International Inc. | Common | 071813109 | 14,472 | 176,698 | SH | | SOLE | | 176,698 | 0 | 0 |
Becton, Dickinson and Co. | Common | 075887109 | 14,727 | 58,438 | SH | | SOLE | | 58,438 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 11,761 | 94,889 | SH | | SOLE | | 94,889 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 102 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Bio-Techne Corporation | Common | 09073M104 | 4,524 | 21,701 | SH | | SOLE | | 21,701 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 52,548 | 224,690 | SH | | SOLE | | 224,690 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 21,050 | 245,763 | SH | | SOLE | | 245,763 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 12,964 | 101,918 | SH | | SOLE | | 101,918 | 0 | 0 |
Blueprint Medicines Corporation | Common | 09627Y109 | 8,959 | 94,976 | SH | | SOLE | | 94,976 | 0 | 0 |
Boston Scientific Corporation | Common | 101137107 | 27,174 | 632,250 | SH | | SOLE | | 632,250 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 33,470 | 738,044 | SH | | SOLE | | 738,044 | 0 | 0 |
Cardinal Health, Inc. | Common | 14149Y108 | 297 | 6,300 | SH | | SOLE | | 6,300 | 0 | 0 |
Celgene Corp. | Common | 151020104 | 136,230 | 1,473,710 | SH | | SOLE | | 1,473,710 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B202 | 19 | 7,053 | SH | | SOLE | | 7,053 | 0 | 0 |
Cellectis SA | Sponsored ADR | 15117K103 | 1,718 | 110,147 | SH | | SOLE | | 110,147 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 2,010 | 14,167 | SH | | SOLE | | 14,167 | 0 | 0 |
Chimerix, Inc. | Common | 16934W106 | 494 | 114,333 | SH | | SOLE | | 114,333 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 267 | 158,784 | SH | | SOLE | | 158,784 | 0 | 0 |
Cigna Corporation | Common | 125523100 | 18,395 | 116,756 | SH | | SOLE | | 116,756 | 0 | 0 |
Clearside Biomedical, Inc. | Common | 185063104 | 161 | 165,330 | SH | | SOLE | | 165,330 | 0 | 0 |
Clovis Oncology, Inc. | Common | 189464100 | 561 | 37,700 | SH | | SOLE | | 37,700 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 6,440 | 291,419 | SH | | SOLE | | 291,419 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 545 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
Concert Pharmaceuticals, Inc. | Common | 206022105 | 1,330 | 110,853 | SH | | SOLE | | 110,853 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 8,400 | 178,348 | SH | | SOLE | | 178,348 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 31,354 | 575,401 | SH | | SOLE | | 575,401 | 0 | 0 |
CymaBay Therapeutics, Inc. | Common | 23257D103 | 631 | 88,102 | SH | | SOLE | | 88,102 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 22,714 | 158,931 | SH | | SOLE | | 158,931 | 0 | 0 |
DENTSPLY SIRONA Inc. | Common | 24906P109 | 7,407 | 126,921 | SH | | SOLE | | 126,921 | 0 | 0 |
Diplomat Pharmacy, Inc. | Common | 25456K101 | 1,308 | 214,845 | SH | | SOLE | | 214,845 | 0 | 0 |
Editas Medicine, Inc. | Common | 28106W103 | 1,113 | 44,989 | SH | | SOLE | | 44,989 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 12,889 | 69,769 | SH | | SOLE | | 69,769 | 0 | 0 |
Eli Lilly and Co. | Common | 532457108 | 28,052 | 253,199 | SH | | SOLE | | 253,199 | 0 | 0 |
Endo International plc | Shares | G30401106 | 2,190 | 531,570 | SH | | SOLE | | 531,570 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 5,015 | 399,604 | SH | | SOLE | | 399,604 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 8,588 | 184,607 | SH | | SOLE | | 184,607 | 0 | 0 |
Evolent Health, Inc. | Common | 30050B101 | 1,385 | 174,270 | SH | | SOLE | | 174,270 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 14,499 | 678,467 | SH | | SOLE | | 678,467 | 0 | 0 |
Fate Therapeutics, Inc. | Common | 31189P102 | 495 | 24,379 | SH | | SOLE | | 24,379 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 11,038 | 244,320 | SH | | SOLE | | 244,320 | 0 | 0 |
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 716 | 300,781 | SH | | SOLE | | 300,781 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 6,256 | 48,525 | SH | | SOLE | | 48,525 | 0 | 0 |
Genomic Health, Inc. | Common | 37244C101 | 1,543 | 26,531 | SH | | SOLE | | 26,531 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 124,048 | 1,836,112 | SH | | SOLE | | 1,836,112 | 0 | 0 |
GlaxoSmithKline PLC | Shares | 37733W105 | 8,752 | 218,700 | SH | | SOLE | | 218,700 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 3,551 | 67,516 | SH | | SOLE | | 67,516 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 771 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
GW Pharmaceuticals PLC | ADS | 36197T103 | 11,119 | 64,499 | SH | | SOLE | | 64,499 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 12,107 | 89,569 | SH | | SOLE | | 89,569 | 0 | 0 |
HCP, Inc. | Common | 40414L109 | 1,455 | 45,500 | SH | | SOLE | | 45,500 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 421946104 | 2,130 | 68,000 | SH | | SOLE | | 68,000 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,262 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
HealthEquity, Inc. | Common | 42226A107 | 2,080 | 31,810 | SH | | SOLE | | 31,810 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 2,051 | 42,701 | SH | | SOLE | | 42,701 | 0 | 0 |
Horizon Therapeutics plc | Shares | G46188101 | 3,789 | 157,473 | SH | | SOLE | | 157,473 | 0 | 0 |
Humana Inc. | Common | 444859102 | 12,767 | 48,122 | SH | | SOLE | | 48,122 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 17,003 | 61,754 | SH | | SOLE | | 61,754 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 73,067 | 198,471 | SH | | SOLE | | 198,471 | 0 | 0 |
ImmunoGen, Inc. | Common | 45253H101 | 365 | 168,190 | SH | | SOLE | | 168,190 | 0 | 0 |
Immunomedics, Inc. | Common | 452907108 | 5,400 | 389,313 | SH | | SOLE | | 389,313 | 0 | 0 |
Incyte Corp. | Common | 45337C102 | 43,409 | 510,933 | SH | | SOLE | | 510,933 | 0 | 0 |
Inogen, Inc. | Common | 45780L104 | 935 | 14,000 | SH | | SOLE | | 14,000 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 2,460 | 150,290 | SH | | SOLE | | 150,290 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 4,285 | 53,857 | SH | | SOLE | | 53,857 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 715 | 55,096 | SH | | SOLE | | 55,096 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 29,204 | 55,675 | SH | | SOLE | | 55,675 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 8,201 | 127,598 | SH | | SOLE | | 127,598 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common | 462260100 | 4,881 | 199,073 | SH | | SOLE | | 199,073 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 2,637 | 16,391 | SH | | SOLE | | 16,391 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 9,619 | 67,471 | SH | | SOLE | | 67,471 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 123,960 | 890,004 | SH | | SOLE | | 890,004 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 3,722 | 85,400 | SH | | SOLE | | 85,400 | 0 | 0 |
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 5,433 | 31,424 | SH | | SOLE | | 31,424 | 0 | 0 |
Ligand Pharmaceuticals Inc. | Common | 53220K504 | 5,029 | 44,055 | SH | | SOLE | | 44,055 | 0 | 0 |
LivaNova PLC | Shares | G5509L101 | 3,287 | 45,681 | SH | | SOLE | | 45,681 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,640 | 145,421 | SH | | SOLE | | 145,421 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,398 | 13,340 | SH | | SOLE | | 13,340 | 0 | 0 |
Mallinckrodt plc | Sponsored ADR | G5785G107 | 303 | 32,980 | SH | | SOLE | | 32,980 | 0 | 0 |
Masimo Corp. | Common | 574795100 | 4,127 | 27,732 | SH | | SOLE | | 27,732 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 12,860 | 95,691 | SH | | SOLE | | 95,691 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 3,262 | 187,063 | SH | | SOLE | | 187,063 | 0 | 0 |
The Medicines Company | Common | 584688105 | 10,142 | 278,092 | SH | | SOLE | | 278,092 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 46,751 | 480,035 | SH | | SOLE | | 480,035 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 84,998 | 1,013,695 | SH | | SOLE | | 1,013,695 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 3,591 | 245,114 | SH | | SOLE | | 245,114 | 0 | 0 |
Milestone Pharmaceuticals, Inc. | Common | 59935V107 | 1,358 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 1,400 | 13,590 | SH | | SOLE | | 13,590 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 1,203 | 144,110 | SH | | SOLE | | 144,110 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 957 | 39,643 | SH | | SOLE | | 39,643 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 17,958 | 943,152 | SH | | SOLE | | 943,152 | 0 | 0 |
MyoKardia, Inc. | Common | 62857M105 | 1,935 | 38,600 | SH | | SOLE | | 38,600 | 0 | 0 |
Myriad Genetics, Inc. | Common | 62855J104 | 571 | 20,549 | SH | | SOLE | | 20,549 | 0 | 0 |
Natus Medical Inc. | Common | 639050103 | 1,573 | 61,219 | SH | | SOLE | | 61,219 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 10,093 | 283,679 | SH | | SOLE | | 283,679 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 17,484 | 207,078 | SH | | SOLE | | 207,078 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 1,062 | 158,047 | SH | | SOLE | | 158,047 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 25,297 | 277,047 | SH | | SOLE | | 277,047 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 167 | 28,550 | SH | | SOLE | | 28,550 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 12,301 | 241,000 | SH | | SOLE | | 241,000 | 0 | 0 |
Novocure Ltd. | Ordinary Shares | G6674U108 | 3,419 | 54,074 | SH | | SOLE | | 54,074 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 10,024 | 272,766 | SH | | SOLE | | 272,766 | 0 | 0 |
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 690 | 372,733 | SH | | SOLE | | 372,733 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 1,034 | 21,718 | SH | | SOLE | | 21,718 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 89,597 | 2,068,265 | SH | | SOLE | | 2,068,265 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 5,300 | 303,908 | SH | | SOLE | | 303,908 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 6,812 | 1,449,269 | SH | | SOLE | | 1,449,269 | 0 | 0 |
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 3,132 | 115,448 | SH | | SOLE | | 115,448 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 15,170 | 153,003 | SH | | SOLE | | 153,003 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,469 | 121,341 | SH | | SOLE | | 121,341 | 0 | 0 |
PTC Therapeutics, Inc. | Common | 69366J200 | 6,282 | 139,608 | SH | | SOLE | | 139,608 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 907 | 71,340 | SH | | SOLE | | 71,340 | 0 | 0 |
Quest Diagnostics Inc. | Common | 74834L100 | 2,648 | 26,012 | SH | | SOLE | | 26,012 | 0 | 0 |
Quorum Health Corp. | Common | 74909E106 | 33 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 577 | 19,190 | SH | | SOLE | | 19,190 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 52,261 | 166,968 | SH | | SOLE | | 166,968 | 0 | 0 |
REGENXBIO Inc. | Common | 75901B107 | 658 | 12,801 | SH | | SOLE | | 12,801 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 6,359 | 52,110 | SH | | SOLE | | 52,110 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | Common | 76243J105 | 548 | 24,890 | SH | | SOLE | | 24,890 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 9,180 | 466,247 | SH | | SOLE | | 466,247 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 15,406 | 84,145 | SH | | SOLE | | 84,145 | 0 | 0 |
Sangamo Therapeutics, Inc. | Common | 800677106 | 1,301 | 120,768 | SH | | SOLE | | 120,768 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 3,719 | 85,941 | SH | | SOLE | | 85,941 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 22,465 | 147,847 | SH | | SOLE | | 147,847 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 20,066 | 289,925 | SH | | SOLE | | 289,925 | 0 | 0 |
Senior Housing Properties Trust | Common | 81721M109 | 2,958 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Smith & Nephew plc | Shares | 83175M205 | 6,998 | 160,734 | SH | | SOLE | | 160,734 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 7,808 | 89,022 | SH | | SOLE | | 89,022 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 987 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 4,315 | 28,981 | SH | | SOLE | | 28,981 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 21,164 | 102,950 | SH | | SOLE | | 102,950 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 7,298 | 641,268 | SH | | SOLE | | 641,268 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 1,483 | 29,027 | SH | | SOLE | | 29,027 | 0 | 0 |
Takeda Pharmaceutical SP ADR | Sponsored ADS | 874060205 | 3,153 | 178,128 | SH | | SOLE | | 178,128 | 0 | 0 |
Teleflex Inc. | Common | 879369106 | 2,112 | 6,379 | SH | | SOLE | | 6,379 | 0 | 0 |
Tenet Healthcare Corp. | Common | 88033G407 | 3,774 | 182,671 | SH | | SOLE | | 182,671 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 413 | 859,322 | SH | | SOLE | | 859,322 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 7,253 | 785,851 | SH | | SOLE | | 785,851 | 0 | 0 |
TherapeuticsMD, Inc. | Common | 88338N107 | 1,409 | 541,815 | SH | | SOLE | | 541,815 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 39,999 | 136,198 | SH | | SOLE | | 136,198 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 146 | 446,099 | SH | | SOLE | | 446,099 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 2,443 | 38,480 | SH | | SOLE | | 38,480 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 1,544 | 19,751 | SH | | SOLE | | 19,751 | 0 | 0 |
United Therapeutics Corporation | Class B | 91307C102 | 4,223 | 54,094 | SH | | SOLE | | 54,094 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 79,092 | 324,133 | SH | | SOLE | | 324,133 | 0 | 0 |
Varian Medical Systems, Inc. | Common | 92220P105 | 3,271 | 24,027 | SH | | SOLE | | 24,027 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 6,732 | 98,496 | SH | | SOLE | | 98,496 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 1,471 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 89,807 | 489,734 | SH | | SOLE | | 489,734 | 0 | 0 |
Viking Therapeutics, Inc. | Common | 92686J106 | 946 | 114,016 | SH | | SOLE | | 114,016 | 0 | 0 |
WaVe Life Sciences Ltd. | Shares | Y95308105 | 1,460 | 55,955 | SH | | SOLE | | 55,955 | 0 | 0 |
WellCare Health Plans, Inc. | Common | 94946T106 | 5,099 | 17,886 | SH | | SOLE | | 17,886 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 12,419 | 152,322 | SH | | SOLE | | 152,322 | 0 | 0 |
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 2,043 | 68,506 | SH | | SOLE | | 68,506 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 2,963 | 72,382 | SH | | SOLE | | 72,382 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 9,378 | 79,654 | SH | | SOLE | | 79,654 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 28,212 | 248,584 | SH | | SOLE | | 248,584 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 5,932 | 124,148 | SH | | SOLE | | 124,148 | 0 | 0 |